BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,465,000 | +25.1% | 10,000 | 0.0% | 0.02% | +4.8% |
| Q3 2014 | $3,568,000 | +16.0% | 10,000 | 0.0% | 0.02% | +16.7% |
| Q2 2014 | $3,076,000 | -8.7% | 10,000 | 0.0% | 0.02% | +20.0% |
| Q1 2014 | $3,369,000 | -3.2% | 10,000 | 0.0% | 0.02% | +7.1% |
| Q4 2013 | $3,480,000 | -3.2% | 10,000 | 0.0% | 0.01% | -6.7% |
| Q3 2013 | $3,595,000 | +29.6% | 10,000 | 0.0% | 0.02% | +7.1% |
| Q2 2013 | $2,773,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLG Partners LP | 18,250,000 | $50,831,000 | 1.94% |
| MACKAY SHIELDS LLC | 9,117,000 | $25,277,000 | 1.35% |
| Baker Brothers Advisors | 22,898,000 | $63,217,000 | 1.25% |
| Amici Capital, LLC | 8,000,000 | $22,185,000 | 0.81% |
| Verition Fund Management LLC | 1,075,000 | $2,981,000 | 0.55% |
| Pine River Capital Management L.P. | 4,700,000 | $13,089,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $5,570,000 | 0.16% |
| SYMPHONY ASSET MANAGEMENT LLC | 324,000 | $898,000 | 0.09% |
| AVIVA PLC | 2,000,000 | $5,615,000 | 0.06% |
| Cheyne Capital Management (UK) LLP | 2,000,000 | $74,000 | 0.05% |